Add
Compare:
Overview:
There are 17 differences and 2 similarities between Desoxyn, Vyvanse
| Basic Information |
| Generic Name |
| Methamphetamine |
Lisdexamfetamine |
| Class |
| Anorexiants, Cns Stimulants |
Cns Stimulants |
| Prescription Generic Available |
| Yes |
No |
| Pregnancy cat. |
| C(us) |
C(us) |
| Approved Age |
| 6 And Older |
6 And Older |
| Legal Status |
| Schedule Ii (us) |
Pharmacist Only (au) Pom (uk) Schedule Ii (us) |
| Dependence Liability |
| High |
|
| Excretion |
| Renal |
Renal: ~2% |
| Possible Side Effects |
| Some Loss Of Appetite, Weight, Dry Mouth, Headache, Sleep Problems, Irritability, Agitation, Anxiety, Addiction |
Some Loss Of Appetite, Weight Loss, Sleep Problems, Irritability, Tics. |
|
| Dosage, Usage and Forms |
| Routes (of administration) |
| Ingestion, Intravenous, Insufflation, Inhalation, Suppository |
Oral |
| Dosage |
| 5 Mg Q Am–10 Mg Bid |
30 Mg Q Am–70 Mg Q Am |
|
Maximum daily dose |
| 10 mg |
70 mg |
| Duration |
| Short-acting |
Long-acting |
| Duration - time |
| 3-5 H |
8-12 H |
| Chemical Data |
| Molecular mass (g/mol) |
| 149.2337 G/mol |
263.378 G/mol |
| Half Life |
| 9-12 Hours |
< 1 Hour (prodrug Molecule), 12-13 Hours (d-amphetamine) |
| Formula |
| C10h15n |
C15h25n3o |
| Bioavailability |
| 62.7% Oral; 79% Nasal; 90.3% Smoked; 99% Rectally; 100% Iv |
28 % |
| Metabolism |
| Hepatic |
Gastro-intestinal (initial); Hepatic (extensively Cyp2d6) After Conversion To D-amphetamine |